+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-beta binding via a common signaling pathway



Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-beta binding via a common signaling pathway



Journal of Biological Chemistry 277(51): 49304-49310



We determined whether salicylate at pharmacological concentrations inhibits nitric-oxide synthase-2 (NOS-2) and cyclo-oxygenase-2 (COX-2) expressions in RAW 264.7 stimulated with lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma). Cells were treated with sodium salicylate (10(-7)-10(-4) m) or vehicle for 30 min followed by LPS+IFN-gamma for up to 24 h. Salicylate suppressed NOS-2 and COX-2 protein levels and promoter activities stimulated by LPS+IFN-gamma for 4 h in a concentration-dependent manner but had no effect on NOS-2 expression stimulated by the combined agonists for 24 h. Results from promoter analysis indicate that the binding of CCAAT/enhancer-binding protein beta (C/EBPbeta) to its cognate site at -150/-142 on the NOS-2 promoter region was essential for NOS-2 expression at 4 h but not at 24 h. Salicylate reduced C/EBPbeta binding at 4 h and did not alter its binding at 24 h. NOS-2 and COX-2 protein levels and C/EBPbeta binding stimulated by LPS+IFN-gamma for 4 h were inhibited by a similar battery of signaling inhibitors, suggesting a common pathway for NOS-2 and COX-2 expression. Kinetic analysis indicates that NOS-2, similar to COX-2 expression, at 4 h was largely due to the action of LPS, which induced C/EBPbeta binding, whereas its expression at a longer time point was contributed by IFN-gamma. Our findings implicate two distinct pathways for NOS-2 expression induced by LPS+IFN-gamma. Salicylate at pharmacological concentrations is capable of suppressing the early phase of NOS-2 and COX-2 expression by blocking C/EBPbeta binding.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011322486

Download citation: RISBibTeXText

PMID: 12379662

DOI: 10.1074/jbc.m205030200


Related references

Salicylate Suppresses Macrophage Nitric-oxide Synthase-2 and Cyclo-oxygenase-2 Expression by Inhibiting CCAAT/Enhancer-binding Protein-b Binding via a Common Signaling Pathway. The Journal of Biological Chemistry 277(51): 304-10, 2002

CCAAT/enhancer-binding protein beta regulates nitric oxide synthase 2 gene expression in mTAL cells. Journal of the American Society of Nephrology 7(9): 1825, 1996

CCAAT box enhancer binding protein beta mediates hypoxia-enhanced inducible nitric oxide synthase expression in rat pulmonary microvascular smooth muscle cells. FASEB Journal 15(5): A761, 2001

Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108(2): 518-524, 2006

CCAAT/enhancer binding protein-beta trans-activates murine nitric oxide synthase 2 gene in an MTAL cell line. American Journal of Physiology 276(4 Pt 2): F599-F605, 1999

Sakuranetin downregulates inducible nitric oxide synthase expression by affecting interleukin-1 receptor and CCAAT/enhancer-binding protein β. Journal of Natural Medicines 73(2): 353-368, 2019

Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein beta and nuclear factor-kappaB in hepatocytes. Genes to Cells 3(5): 321-330, 1998

p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2. Journal of Biological Chemistry 277(33): 29584-29592, 2002

Role of nitric oxide and CCAAT/enhancer-binding protein transcription factor in statin-dependent induction of heme oxygenase-1 in mouse macrophages. Plos one 8(5): E64092, 2013

Inhibition of p90 ribosomal S6 kinase-mediated CCAAT/enhancer-binding protein beta activation and cyclooxygenase-2 expression by salicylate. Journal of Biological Chemistry 280(18): 18411-7, 2005

CCAAT/enhancer binding protein-β trans-activates murine nitric oxide synthase 2 gene in an MTAL cell line. American Journal of Physiology. Renal Physiology 276(4): F599-F605, 2018

CCAAT/enhancer binding protein-b trans-activates murine nitric oxide synthase 2 gene in an MTAL cell line. American Journal of Physiology 276(4): 99-F605, 1999

Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts. Journal of Biological Chemistry 276(22): 18897-18904, 2001

Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated livers. Molecular Biology of the Cell 9(6): 1479-1494, 1998

P38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kB, cAMP response element-binding protein, CCAAT/enhancer-binding protein-b, and activating transcription factor-2. The Journal of Biological Chemistry 277(33): 584-92, 2002